| Ask Questions (ASQ):Implementation of a Communication Intervention (NCT05025748) | Barbara Ann Karmanos Cancer Institute | 2021-08-25 |
| Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer (NCT04553770) | Jonsson Comprehensive Cancer Center | 2020-10-09 |
| Researching the Effect of Exercise on Cancer (NCT04589468) | City of Hope Medical Center | 2020-10-02 |
| MARGetuximab Or Trastuzumab (MARGOT) (NCT04425018) | Dana-Farber Cancer Institute | 2020-07-13 |
| A Trail of Neoadjuvant Endostar in Combination With Chemotherapy in Breast Cancer (NCT01907529) | Hebei Medical University Fourth Hospital | 2019-08-01 |
| Exercise Intervention in Targeting Adiposity and Inflammation With Movement to Improve Prognosis in Breast Cancer (NCT03091842) | University of Southern California | 2019-07-29 |
| Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Stage IV or Unresectable, Recurrent Triple Negative Breast Cancer (NCT03971409) | Laura Huppert, MD, BA | 2019-07-08 |
| Acupuncture Pilot Study for Cancer-related Cognitive Function (NCT04007770) | Memorial Sloan Kettering Cancer Center | 2019-07-01 |
| Living Well After Breast Surgery (NCT03834532) | University of Texas at Austin | 2019-02-18 |
| Atezolizumab and Cobimetinib or Idasanutlin in Participants With Stage IV or Unresectable Recurrent Estrogen Receptor Positive Breast Cancer (NCT03566485) | Vanderbilt-Ingram Cancer Center | 2018-07-10 |
| HER2 Directed Dendritic Cell Vaccine During Neoadjuvant Therapy of HER2+Breast Cancer (NCT03387553) | H. Lee Moffitt Cancer Center and Research Institute | 2018-06-06 |
| Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partners (NCT03112668) | Rutgers, The State University of New Jersey | 2017-12-06 |
| 4-1BB Agonist Monoclonal Antibody PF-05082566 With Trastuzumab Emtansine or Trastuzumab in Treating Patients With Advanced HER2-Positive Breast Cancer (NCT03364348) | George W. Sledge Jr. | 2017-10-30 |
| Aerobic and Strength Training Exercise in Improving Fitness and Arm Health During and After Radiation Therapy in Patients With Stage II-III Breast Cancer (NCT03102866) | Ohio State University Comprehensive Cancer Center | 2017-08-30 |
| Exercise in Targeting Metabolic Dysregulation in Stage I-III Breast or Prostate Cancer Survivors (NCT03284346) | University of Southern California | 2017-08-17 |
| Copanlisib, Letrozole, and Palbociclib in Treating Patients With Hormone Receptor Positive HER2 Negative Stage I-IV Breast Cancer (NCT03128619) | Jonsson Comprehensive Cancer Center | 2017-08-02 |
| Alisertib With or Without Fulvestrant in Treating Patients With Locally Advanced or Metastatic, Endocrine-Resistant Breast Cancer (NCT02860000) | Mayo Clinic | 2017-07-06 |
| Study of AVB-620 in Women With Primary, Nonrecurrent Breast Cancer Undergoing Surgery (NCT03113825) | Avelas Biosciences, Inc. | 2017-07-05 |
| Pembrolizumab and Capecitabine in Treating Patients With Locally Advanced or Metastatic Triple Negative or Hormone-Refractory Breast Cancer That Cannot Be Removed by Surgery (NCT03044730) | Northwestern University | 2017-05-25 |
| Ultrasound in Detecting Taxane-Induced Neuropathy in Patients With Breast Cancer (NCT03139435) | Wake Forest University Health Sciences | 2017-05-11 |
| Vaccine Therapy in Preventing Cancer Recurrence in Patients With Non-Metastatic, Node Positive, HER2 Negative Breast Cancer That is in Remission (NCT02780401) | University of Washington | 2016-09-02 |
| Platinum in Treating Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy (NCT02445391) | ECOG-ACRIN Cancer Research Group | 2015-10-20 |
| Carevive Survivor Care Planning System in Improving Quality of Life in Breast Cancer Survivors (NCT03198286) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2015-08-01 |
| Vaccine Therapy in Treating Patients With HER2-Negative Stage III-IV Breast Cancer (NCT02157051) | University of Washington | 2015-06-01 |
| T-DM1+Pertuzumab in Pre-OP Early-Stage HER2+ BRCA (NCT02326974) | Dana-Farber Cancer Institute | 2015-01-01 |
| Neoadjuvant Trial of Capecitabine for Axillary Lymph Node Positive Operable Breast Cancer (NCT02115152) | Guangxi Medical University | 2014-06-01 |
| A Pilot Study of Acupuncture for Chemotherapy-induced Peripheral Neuropathy in Breast Cancer Patients (NCT02129686) | Dana-Farber Cancer Institute | 2014-06-01 |
| Detection and Prevention of Anthracycline-Related Cardiac Toxicity With Concurrent Simvastatin (NCT02096588) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2014-05-20 |
| Paclitaxel & Cyclophosphamide With or Without Trastuzumab Before Surgery in Treating Previously Untreated Breast Cancer (NCT01750073) | University of Nebraska | 2012-12-07 |
| A Study of Vorinostat and Tamoxifen in Newly Diagnosed Breast Cancer (NCT01194427) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2011-03-01 |
| Trial With Autologous Dendritic Cell Vaccination in Patients With Stage II-III HER2 Negative Breast Cancer (NCT01431196) | Clinica Universidad de Navarra, Universidad de Navarra | 2011-02-01 |
| Vorinostat in Treating Women Who Are Undergoing Surgery For Newly Diagnosed Stage I -III Breast Cancer (NCT00262834) | National Cancer Institute (NCI) | 2005-10-01 |
| Capecitabine in Women With Operable Breast Cancer (NCT00148720) | Dana-Farber Cancer Institute | 2004-09-01 |
| Preoperative Herceptin and Navelbine for Breast Cancer (NCT00148681) | Dana-Farber Cancer Institute | 2001-05-01 |